08
Sep
What happened?
President Trump on July 21 announced via social media a proposed tariff framework for imported generic pharmaceuticals to encourage domestic manufacturing. Under the announced framework, imported generic drugs would remain subject to no additional tariffs for a two-year transition period starting August 1, 2026. The tariff rate would then increase to 100% beginning August 1, 2028, and increase again to 200% beginning August 1, 2029. The announcement states that the existing policy applicable to patented, branded, and innovative...